<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122646">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01846572</url>
  </required_header>
  <id_info>
    <org_study_id>RUB-Neuro-2013-clopi</org_study_id>
    <nct_id>NCT01846572</nct_id>
  </id_info>
  <brief_title>Clopidogrel Response in Acute Ischemic Stroke</brief_title>
  <acronym>Bo-CRISP</acronym>
  <official_title>Prevalence of Low Response to Clopidogrel in Patients After Acute Ischemic Stroke. The Bochumer CRISP Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruhr University of Bochum</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ruhr University of Bochum</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to determine the prevalence rate and risk factors for chemical
      laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Result of platelet function test</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Aggregometry result of antiplatelet therapy</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">159</enrollment>
  <condition>Ischemic Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with an acute ischemic stroke admitted to our hospital and treated with
        clopidogrel
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute ischemic stroke

          -  admittance to stroke unit

          -  clopidogrel medication

        Exclusion Criteria:

          -  no consent

          -  prior bleeding disorders

          -  severe liver disorders

          -  current gastrointestinal disorders

          -  congestive heart failure

          -  life-threatening malignancies
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saskia H Meves, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ruhr University Bochum, Department of Neurology</affiliation>
  </overall_official>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>May 2, 2013</lastchanged_date>
  <firstreceived_date>April 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ruhr University of Bochum</investigator_affiliation>
    <investigator_full_name>Saskia Meves</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Clopidogrel</keyword>
  <keyword>Aggregometry</keyword>
  <keyword>Antiplatelet therapy</keyword>
  <keyword>Platelet function tests</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Clopidogrel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
